CareLit Fachartikel

Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wildtype MLL

K Ahmad, C Katryniok, B Scholz, J Merkens, R Marschalek, D Steinhilber · Klinische Pädiatrie · 2015 · Heft 07

Dokument
1200303
CareLit-ID
Jahr
2015
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
K Ahmad, C Katryniok, B Scholz, J Merkens, R Marschalek, D Steinhilber
Ausgabe
Heft 07 / 2015
Seiten
–
Erschienen: 2015-07-27 00:00:00
ISSN
0300-8630

Zusammenfassung

The ALOX5 gene encodes 5-lipoxygenase (5-LO), a key enzyme of inflammatory reactions. 5-LO expression is induced by VitD3 and/or TGFβ and transcription initiation was associated with an increase in histone H3 lysine 4 trimethylation (H3K4me3) in a TSA-inducible fashion. Therefore, we investigated the effects of the MLL protein and its derivatives, MLL-AF4 and AF4-MLL, respectively. MLL-AF4 was able to enhance ALOX5 promoter activity by 47-fold which was further stimulated when either VDR/RXR or SMAD3/SMAD4 were co-transfected. Additionally, we investigated several HDAC inhibitors in combination with gene knockdo…

Schlagworte

Work 5-Lipoxygenase Klinische Pädiatrie